Linda Assouline currently serves as the Senior Global Medical Director and Head of Medical Capability Excellence at UCB, a position held since December 2019. Previously, Linda Assouline worked at AbbVie for over a decade, where roles included Global Medical Director for the Immunology Portfolio and Global Medical Affairs TA Head for Rheumatology, overseeing strategic development across more than 70 countries and leading initiatives for the Humira brand. Earlier experience includes positions at Abbott and Novartis, where Linda Assouline significantly contributed to medical affairs and launched major pharmaceutical products. Linda Assouline began the professional journey at Sanofi-Aventis as a Senior Clinical Research Associate after earning a Bachelor of Science in Physiology and Experimental Medicine from McGill University and a Ph.D. in Clinical Genetics and Molecular Biology from Université de Montréal.
December, 2019 - present